1. Home
  2. WRBY vs IDYA Comparison

WRBY vs IDYA Comparison

Compare WRBY & IDYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Warby Parker Inc.

WRBY

Warby Parker Inc.

HOLD

Current Price

$26.53

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Logo IDEAYA Biosciences Inc.

IDYA

IDEAYA Biosciences Inc.

HOLD

Current Price

$34.71

Market Cap

2.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WRBY
IDYA
Founded
2010
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Ophthalmic Goods
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.8B
2.9B
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
WRBY
IDYA
Price
$26.53
$34.71
Analyst Decision
Buy
Strong Buy
Analyst Count
15
14
Target Price
$25.43
$49.67
AVG Volume (30 Days)
3.8M
884.5K
Earning Date
02-26-2026
02-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.00
N/A
Revenue
$850,580,000.00
$214,834,000.00
Revenue This Year
$15.66
$2,688.43
Revenue Next Year
$12.88
N/A
P/E Ratio
$11,018.11
N/A
Revenue Growth
14.55
5377.66
52 Week Low
$13.63
$13.45
52 Week High
$31.00
$39.28

Technical Indicators

Market Signals
Indicator
WRBY
IDYA
Relative Strength Index (RSI) 52.02 46.10
Support Level $26.09 $34.01
Resistance Level $30.00 $36.71
Average True Range (ATR) 1.57 1.63
MACD -0.23 -0.29
Stochastic Oscillator 16.71 10.06

Price Performance

Historical Comparison
WRBY
IDYA

About WRBY Warby Parker Inc.

Warby Parker Inc is a mission-driven, lifestyle brand that operates at the intersection of design, technology, healthcare, and social enterprise. The company predominantly derives revenue from the sales of eyewear products, optical services, and accessories. The firm sells products and services through its stores, website, and mobile apps. Revenue generated from eyewear products includes the sales of prescription and non-prescription optical glasses and sunglasses, contact lenses, eyewear accessories, and expedited shipping charges.

About IDYA IDEAYA Biosciences Inc.

IDEAYA Biosciences Inc is an oncology-focused precision medicine company committed to the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its approach integrates small molecule drug discovery with extensive capabilities in identifying and validating translational biomarkers to develop targeted therapies for select patient populations that are likely to benefit from these targeted therapies. The company's clinical-stage product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275/GSK959 (Werner Helicase), IDE161 (PARG), and IDE705/GSK101 (Pol Theta Helicase). In addition, it also working on other development candidates and has multiple earlier-stage preclinical programs.

Share on Social Networks: